Skip to content

Form 4 filed by Ragosa Mark

Ragosa Mark filed this Form 4 on KNSA (Kiniksa Pharmaceuticals International, plc) with 12 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-03 23:32:40 UTC.

Accession
0001835458-26-000014
Filed
2026-11-03
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: KNSA · Kiniksa Pharmaceuticals International, plc (CIK 1730430)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Class A Ordinary Share 2026-11-02M exercised+9,636$10.7630,490D
Class A Ordinary Share 2026-11-02M exercised+5,388$11.135,878D
Class A Ordinary Share 2026-11-02M exercised+12,123$11.9748,001D
Class A Ordinary Share 2026-11-02M exercised+9,636$17.7657,637D
Class A Ordinary Share 2026-11-02S sold-14,027$91.443,610D
Class A Ordinary Share 2026-11-02S sold-10,502$92.0333,108D
Class A Ordinary Share 2026-11-02S sold-12,034$93.1321,074D
Class A Ordinary Share 2026-11-02S sold-220$94.0120,854D
Share Option derivative2026-11-02M exercised-9,636$04,380D
Share Option derivative2026-11-02M exercised-5,388$00D
Share Option derivative2026-11-02M exercised-12,123$00D
Share Option derivative2026-11-02M exercised-9,636$08,760D